Ocular Microsurgery & Laser Centre, Brandon, MB, Canada.
Department of Ophthalmology, Max Rady College of Medicine, University of Manitoba, MB, Canada.
Cornea. 2019 Oct;38(10):1233-1238. doi: 10.1097/ICO.0000000000002073.
To evaluate the efficacy, predictability, and safety of combined corneal collagen cross-linking (CXL), intracorneal ring segment (ICRS) implantation, and superficial phototherapeutic keratectomy (PTK) in patients with keratoconus.
Fifty-five eyes received ICRS implantation, followed by CXL and PTK combination treatment. Patients were followed up for 6 months. Primary outcomes included Logarithm of the Minimum Angle of Resolution (LogMAR) uncorrected distance VA (UDVA) and corrected distance VA (CDVA), sphere, cylinder, mean spherical equivalent, index of surface variance, index of vertical asymmetry, keratoconus index, central keratoconus index, index of height asymmetry, and index of height decentration. Secondary outcomes were higher-order aberrations (HOAs), including HOA total, coma, spherical, secondary astigmatism, and trefoil.
At 6 months, there was a statistically significant improvement in UDVA, CDVA, sphere, and cylinder compared with baseline (P < 0.001). UDVA improved in 14% of the eyes to 20/25 and 96% had at least 20/40 or better spectacle corrected vision; 30.9% of the eyes were within ±0.5 diopter (D), 45.5% of the eyes were within ±1.0 D, and 74.5% of the eyes were within ±2.0 D. For CDVA, 1 eye (2%) lost 3 lines (but gained UDVA), 11% lost 1 line, 38% showed no change, and 49% gained between 1 and 8 lines of vision. Eighty-eight United Arab Emiratespercent of the eyes had at least 1 line of UDVA visual improvement, 79% improved by ≥2 lines, and 69% improved by ≥3 lines. HOA total, coma, spherical aberration, and secondary astigmatism showed improvements of -0.87 (P < 0.001), -0.84 (P < 0.001), -0.10 (P = 0.002), and -0.15 (P = 0.035), respectively.
A combined procedure of ICRS implantation, CXL, and PTK is effective, predictable, and apparently safe for patients diagnosed with moderate keratoconus.
评估角膜交联(CXL)联合角膜内环段(ICRS)植入和表面光疗角膜切削术(PTK)治疗圆锥角膜患者的疗效、可预测性和安全性。
55 只眼接受 ICRS 植入术,随后行 CXL 和 PTK 联合治疗。患者随访 6 个月。主要结局包括未矫正距离视力(UDVA)和矫正距离视力(CDVA)的最小分辨角对数(LogMAR)、球镜、柱镜、平均等效球镜、表面方差指数、垂直非对称指数、圆锥角膜指数、中央圆锥角膜指数、高度不对称指数和高度偏心指数。次要结局为高阶像差(HOA),包括 HOA 总、彗差、球差、二次散光和三叶差。
6 个月时,与基线相比,UDVA、CDVA、球镜和柱镜均有统计学意义上的显著改善(P<0.001)。14%的眼 UDVA 提高到 20/25,96%的眼至少有 20/40 或更好的矫正视力;30.9%的眼屈光度在±0.5 屈光度(D)以内,45.5%的眼屈光度在±1.0 D 以内,74.5%的眼屈光度在±2.0 D 以内。对于 CDVA,1 眼(2%)视力丧失 3 行(但 UDVA 提高),11%的眼视力丧失 1 行,38%的眼视力无变化,49%的眼视力提高 1 至 8 行。88%的眼 UDVA 至少提高 1 行,79%的眼提高≥2 行,69%的眼提高≥3 行。HOA 总、彗差、球差和二次散光分别改善了-0.87(P<0.001)、-0.84(P<0.001)、-0.10(P=0.002)和-0.15(P=0.035)。
对于诊断为中度圆锥角膜的患者,ICRS 植入、CXL 和 PTK 联合治疗是一种有效、可预测且明显安全的方法。